Portugal Stresses Importance of Saudi Initiative to Solve Yemeni Crisis

Eurico Brilhante Dias, Portugal’s Secretary of State for Internationalization. (Photo: Saad al-Dossary)
Eurico Brilhante Dias, Portugal’s Secretary of State for Internationalization. (Photo: Saad al-Dossary)
TT

Portugal Stresses Importance of Saudi Initiative to Solve Yemeni Crisis

Eurico Brilhante Dias, Portugal’s Secretary of State for Internationalization. (Photo: Saad al-Dossary)
Eurico Brilhante Dias, Portugal’s Secretary of State for Internationalization. (Photo: Saad al-Dossary)

A high-ranking Portuguese official said that his country was working to expand the European health protocol, to include third countries, as long as vaccines and certificates meet the requirements in force in the European Union.

Portugal’s Secretary of State for Internationalization Eurico Brilhante Dias said that with the vaccine pass, the ongoing vaccination process and the European Health and Safety Mark, the year 2021 would see a return to growth in tourism activity and better results than in 2020.

In an interview with Asharq Al-Awsat, Dias said that the epidemic has had a negative impact on the global economy, noting that Portugal "is no exception.”

Despite the difficulties, the global outlook for economic recovery is now more positive, with growth projected at 6 percent in 2021 and 4.4 percent in 2022, according to IMF forecasts, he underlined.

On a different note, Dias stressed that the Kingdom was a major player in the region.

Recent initiatives taken by the Saudi Arabia confirm its commitment to future engagements that can lead to regional peace and prosperity, he said, expecting stronger cooperation and dialogue between the European Union and the Gulf states.

On relations between Portugal and Saudi Arabia, he said: “We hope to move forward with negotiations on a bilateral investment treaty, and to soon conclude talks on an air services agreement, realizing how important it is to improve air connectivity between the two sides to explore opportunities for investors in both countries.”

The Portuguese official noted that the two countries have enjoyed diplomatic relations for more than 40 years, as they signed a general agreement for cooperation in 2006 in the fields of economy, trade, investment, science and technology, culture, information, tourism, youth and sports.

He added that his country was looking forward to developing cooperation in other areas such as climate change, renewable energy, water, waste management, tourism, cultural heritage, health and higher education, hoping for cooperation between the Portuguese Space Agency and the Saudi Space Authority.

Dias said he believes that the Saudi Green Initiative was an important step to achieve the common goals of a more sustainable life on the planet, noting that the initiative has set ambitious goals, including increasing the share of renewable energy and reducing carbon emissions.

He stressed in this regard that in 2020, 61.7 percent of Portugal’s total energy production was based on renewables, especially hydraulic energy.

Regarding the situation in Yemen, Dias underlined importance of the Saudi initiative, noting that the Houthi attacks against the Kingdom were totally unacceptable.

On the Libyan level, Dias affirmed his country’s commitment to the European Union’s support to the government of Prime Minister Abdul Hamid Dbeibeh in the successful implementation of the road map agreed upon by the LPDF, and improving the living conditions of all Libyans.

Regarding the negotiations of the Iranian nuclear program and the dangers of Tehran’s activity in the region, the Portuguese Secretary of State for Internationalization noted that his country sees the nuclear agreement as an important pillar in the structure of non-proliferation and disarmament and the best way to ensure the exclusively peaceful nature of Iran’s nuclear program.

“We are closely following the talks that have recently begun between Saudi Arabia and Iran, and dialogue is the first condition for establishing friendly relations with our neighbors. So we encourage them to follow this path and work together for the benefit of the region,” he stated.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.